15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 1.2% per year over the past 5 years.
Net income has grown slower than revenue (-0.1% vs 1.2% per year).
Operating margin has expanded, at 11.9% in the latest year.
Free cash flow has declined 34.6% per year over the past 5 years.
Financial health
Total debt ($10.4B) exceeds cash ($260M); net debt is $10.1B.
Total debt has grown slower than revenue (-3.2% vs 1.2% per year).
Total debt is 5.4× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$12.5B
$509M
85.1%
11.9%
$208M
$10.4B
$260M
2024
$12.6B
-$516M
84.6%
4.3%
$120M
$11.5B
$37M
2023
$12.5B
-$133M
84.0%
7.7%
-$257M
$11.5B
$38M
2022
$12.2B
$46M
83.8%
6.7%
-$115M
$11.6B
$118M
2021
$12.4B
$230M
83.5%
11.3%
-$600M
$12.1B
$507M
2020
$11.8B
$511M
83.3%
9.6%
$1.7B
$12.2B
$1.7B
2019
$13.2B
-$675M
83.7%
4.9%
-$53M
$13.4B
$216M
2018
$14.2B
-$788M
83.4%
1.5%
-$253M
$13.6B
$196M
2017
$15.4B
-$2.5B
82.6%
-12.2%
$209M
$13.9B
$563M
2016
$18.4B
-$1.7B
83.7%
-4.7%
$393M
$15.2B
$238M
2015
—
$158M
—
—
-$32M
$17.1B
$184M
2014
—
$92M
—
—
$762M
$16.9B
$509M
2013
—
$141M
—
—
$475M
$9.5B
$373M
2012
—
$266M
—
—
$511M
$9.5B
$388M
2011
—
$202M
—
—
$485M
$8.8B
$130M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$3.0B
-$58M
85.1%
9.5%
-$373M
$10.1B
$712M
Dec '25
$3.1B
$110M
85.6%
14.5%
$172M
$10.4B
$260M
Sep '25
$3.1B
$130M
85.1%
7.9%
$4M
$10.6B
$123M
Jun '25
$3.1B
$282M
85.0%
16.3%
-$3M
$10.8B
$456M
Mar '25
$3.2B
-$13M
84.5%
9.0%
$35M
$11.3B
$431M
Dec '24
$3.3B
-$70M
84.5%
8.5%
$107M
$11.5B
$37M
Sep '24
$3.1B
-$391M
84.8%
-6.6%
-$3M
$11.5B
$33M
Jun '24
$3.1B
-$13M
84.6%
7.6%
$13M
$11.5B
$39M
Mar '24
$3.1B
-$41M
84.5%
7.4%
$3M
$11.5B
$48M
Dec '23
$3.2B
$47M
84.5%
10.3%
-$20M
$11.5B
$38M
Sep '23
$3.1B
-$91M
84.2%
5.6%
-$101M
$11.8B
$91M
Jun '23
$3.1B
-$38M
83.8%
7.9%
-$19M
$11.7B
$118M
Mar '23
$3.1B
-$51M
83.7%
6.8%
-$117M
$11.7B
$144M
Dec '22
$3.1B
$415M
84.2%
7.3%
-$122M
$11.6B
$118M
Sep '22
$3.0B
-$42M
83.7%
6.7%
$44M
$11.9B
$300M
Jun '22
$2.9B
-$326M
83.4%
4.1%
-$41M
$12.2B
$346M
Mar '22
$3.1B
-$1M
84.0%
8.7%
$4M
$12.2B
$460M
Dec '21
$3.2B
$178M
83.9%
13.1%
-$666M
$12.1B
$507M
Sep '21
$3.1B
$111M
83.0%
10.9%
-$2M
$12.0B
$1.3B
Jun '21
$3.0B
$6M
83.4%
10.4%
$72M
$11.9B
$1.3B
Valuation over time
How the market has priced CYH against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 15.0× (Mar '23) to 9.6× (Dec '23).
The price-to-sales ratio has fallen from 0.1× (Mar '23) to 0.0× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is CYH growing its revenue and profit?
Over the past 5 years, Community Health Systems Inc's revenue has grown 1.2% per year, and net income declined 0.1% per year. These are computed facts, not advice.
How much debt does CYH have?
As of FY2025, Community Health Systems Inc reported $10.4B of total debt against $260M of cash.
What is CYH's profit margin?
In FY2025, gross margin was 85.1%, operating margin 11.9%, and net margin 4.1%.
What is CYH's P/E ratio?
As of Jun '26, Community Health Systems Inc traded at a price-to-earnings ratio of about 9.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.